{
  "postTime": 1765022013000,
  "authorId": "0x5dffeacf3b34f1cc6c7009dd0c5924e7b8f41670",
  "tags": [
    "Health"
  ],
  "title": "The American Exception",
  "preview": "Why the U.S. spends more on health care than any other country &#8212; and gets less in return",
  "body": "[![](https://substackcdn.com/image/fetch/$s_!VB9o!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc66b6bf4-1e6c-4d94-989e-fb80eaa9a0ce_1244x648.jpeg)](https://substackcdn.com/image/fetch/$s_!VB9o!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc66b6bf4-1e6c-4d94-989e-fb80eaa9a0ce_1244x648.jpeg)\n\nThe exam room smelled faintly of disinfectant and wet paper. Martin Rosen sat on the padded bench, his shoes dangling above the floor tiles, staring at the folded edge of a bill that would soon arrive in his mailbox: $167 for the privilege of waiting. The air vent hummed above him; the nurse’s shoes squeaked once on the linoleum, then were gone.\n\nIn Copenhagen, his cousin Anna had the same check-up last week. No bill. No clipboard. She didn’t even bring a wallet. When he asked how that was possible, she laughed and said, “You mean how is your system possible?” The question stayed with him as the lights flickered above his head.\n\nHe suspected his frustration wasn’t unique. It wasn’t. Across the United States, that same hum—of machines, vents, billing servers—underscores an economy that treats health as transaction. Martin’s small annoyance was simply the audible version of a national condition.\n\nA week later, Martin called his doctor’s office about a refill. The receptionist, cheerful but mechanical, said she’d need to confirm his “coverage tier.” He hung up and muttered that he didn’t know his own blood type but he knew his deductible by heart. The line between medicine and money had blurred so completely that no one seemed to notice it anymore.\n\nThe economist Uwe Reinhardt once reduced this entire paradox to five words: “It’s the prices, stupid.” Americans don’t see doctors more often than anyone else; they simply pay more each time they do. A hospital bed in Phoenix costs three times what it does in Paris. A hip replacement in Boston can run $60,000; in Sweden, $14,000. The surgery is the same; the code is different.\n\nDr. Janet Feldman, a retired surgeon from Maine, keeps a drawer full of old invoices—hand-typed bills from a different era. “We used to charge four hundred dollars for an appendectomy in the eighties,” she said. “By 2010, the hospital billed eighteen thousand. The surgery didn’t change. The codes did.”\n\n“It’s not the patient who overuses the system,” Feldman added, tightening the cap on her thermos, “it’s the system that overcharges the patient.”\n\nIn the American system, every actor in the chain—insurers, hospitals, device makers, drug companies—sets prices behind closed doors, each guarding its margin. No other developed nation allows that opacity on a national scale. Even now, when Medicare has finally gained limited power to negotiate drug prices, the rule applies to only ten medicines and excludes private insurance altogether. The rest are priced like luxury goods, determined not by cost but by leverage.\n\nEach form, each code, each denial adds a little more distance between the patient and the care they actually need.\n\nMartin’s cousin Leah, who runs operations at a Toronto hospital, laughed when he described the U.S. billing labyrinth. She oversees her entire finance department in a room smaller than an American waiting area. “We send one invoice to one payer,” she said. “If there’s a problem, we fix it that day.” Then she paused, thinking of his mountain of paperwork. “You don’t need a Ph.D. to see the inefficiency,” she said, “you need a calculator and a conscience.”\n\nAdministrative waste has become the quiet hemorrhage of American health care. Analysts estimate that roughly $265 billion a year—about eight percent of all spending—vanishes into billing and insurance paperwork. U.S. hospitals now employ more clerical staff than nurses. The American Medical Association reports that physicians spend two hours on documentation for every hour of patient care.\n\nMartin imagined those hours as he drove past the medical complex on his way home: windowless offices stacked above one another, fluorescent lights humming, printers exhaling the smell of toner and paper. That antiseptic odor from the exam room followed him into the parking lot.\n\nIn countries where paperwork doesn’t dominate, the hum sounds different. Germany’s sickness funds, France’s national plan, the Netherlands’ regulated private insurers—all operate on a simple premise: health care as a public utility first, a business second. The details vary, but the outcomes converge. Citizens in those countries live longer, see doctors more often, and spend half as much. The United States devotes nearly eighteen percent of its economy to health care; most peers spend around ten.\n\nWhen told this comparison, Feldman sighed. “Other nations don’t spend less because they ration more,” she said, “they spend less because they plan better.”\n\nPlanning, in that sense, doesn’t mean central control; it means coordination—of prices, of data, of incentives.\n\nAmerica has chosen competitive chaos instead: employer insurance for workers, Medicare for the elderly, Medicaid for the poor, Veterans Health for some, ACA marketplaces for others. Each program has its own rules, its own forms, its own lobbyists. Millions fall through the cracks.\n\nCoordination isn’t a utopian idea; it’s a proven one.\n\nHistory offers proof that coordination works. When Lyndon Johnson signed Medicare into law in 1965, hospital administrators warned it would bankrupt the nation. Half a century later, Medicare’s per-person cost growth is lower than that of private insurance. Canada’s single-payer system faced similar panic in the 1970s but stabilized within a decade, now covering everyone for roughly half the U.S. price.\n\nIf American health care is exceptional, it’s in how it protects its inefficiency. Hospital systems merge to gain leverage. Insurers merge to counter them. Drug makers lobby to extend patents. The result is a market where no one controls the system, yet everyone profits from its disorder.\n\nWhen Martin’s bill finally arrives, it’s printed on thick paper with four pages of explanation and one that matters: Amount Due $167.00. The rest is a cloud of codes and disclaimers—CPT 99213, “established patient, fifteen minutes,” and, at the bottom, “This is not a bill. You may receive additional statements.”\n\nHe folds it once and sets it aside. The paper smells faintly of disinfectant, and he wonders if Anna’s clinic in Copenhagen even owns a printer.\n\nLater that night, he tells his wife, “The high cost of health care is just another subscription I can’t cancel.” She laughs, but the joke lands hard. Every month, premiums, co-pays, and deductibles siphon a quiet tithe from their account. Behind each charge is a policy choice someone else made long ago.\n\nIf the country ever decides to rebuild its system, it will have to do more than trim waste. It will have to confront the industries that profit from confusion, invest in primary care that prevents illness instead of monetizing it, and accept that universal coverage is cheaper than its absence. Other nations have already proven that lesson.\n\nThe paper smells faintly of disinfectant — a small, sterile reminder of a system that could be clean, but isn’t yet.\n\n⸻\n\n**Bibliography**\n\n1\\. Centers for Medicare & Medicaid Services. _National Health Expenditure Data for 2023._ CMS, 2024. Comprehensive federal dataset detailing total U.S. health spending, per‑capita averages, and GDP share.\n\n2\\. Commonwealth Fund. _Mirror, Mirror 2021: Reflecting Poorly._ August 2021. Comparative analysis ranking the U.S. last among high‑income countries on access, equity, and outcomes.\n\n3\\. Reinhardt, Uwe E., Gerard F. Anderson, and Peter S. Hussey. “It’s the Prices, Stupid: Why the United States is So Different from Other Countries.” _Health Affairs_ 22, no. 3 (2003). Foundational study identifying unit‑price differences as the primary cause of U.S. cost excess.\n\n4\\. RAND Corporation. _International Prescription Drug Price Comparisons._ 2023. Empirical comparison showing U.S. brand‑name drug prices average 2.8× OECD peers.\n\n5\\. Himmelstein, David, and Steffie Woolhandler. “Administrative Waste in the U.S. Health Care System.” _Health Affairs_ 39 (2020). Quantifies billing overhead at roughly 8 percent of national health expenditure.\n\n6\\. American Medical Association. _Survey on Prior Authorization and Administrative Burden._ 2023. Reports physicians spend two hours on paperwork per hour of patient care.\n\n7\\. Organisation for Economic Co‑operation and Development (OECD). _Health at a Glance 2023._ Paris: OECD Publishing, 2023. Provides cross‑country data showing U.S. health spending nearly double the OECD average.\n\n8\\. Canadian Institute for Health Information. _National Health Expenditure Trends 2024._ CIHI, 2024. Chronicles Canada’s single‑payer cost trajectory compared with the U.S. over five decades.",
  "readTime": 1
}